SUNPHARMA.NS

Sun Pharmaceutical Industries Limited [SUNPHARMA.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SUNPHARMA.NS Stock Summary

Top 10 Correlated ETFs

SUNPHARMA.NS


Top 10 Correlated Stocks

SUNPHARMA.NS


In the News

SUNPHARMA.NS Financial details

Company Rating
Buy
Market Cap
3860.2B
Income
89.06B
Revenue
466.71B
Book val./share
-
Cash/share
-
Dividend
11.5
Dividend %
0.87%
Employees
41K
Optionable
No
Shortable
Yes
Earnings
24 May 2024
P/E
37.16
Forward P/E
34.57
PEG
2.15
P/S
6.96
P/B
5.31
P/C
-
P/FCF
-
Quick Ratio
1.81
Current Ratio
2.62
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
37.1
EPS next Y
46.88
EPS next Q
8.56
EPS this Y
159.56%
EPS next Y
26.35%
EPS next 5Y
74.93%
EPS last 5Y
26.01%
Revenue last 5Y
8.57%
Revenue Q/Q
1.28%
EPS Q/Q
6.06%
-
-
-
-
SMA20
1.35%
SMA50
19.71%
SMA100
40.23%
Inst Own
0%
Inst Trans
0%
ROA
11%
ROE
30%
ROC
0.16%
Gross Margin
77%
Oper. Margin
23%
Profit Margin
19%
Payout
-
Shs Outstand
2.4B
Shs Float
1.02B
-
-
-
-
Target Price
-
52W Range
922.45-1627.0
52W High
-0.4%
52W Low
+75.76%
RSI
64
Rel Volume
1.85
Avg Volume
2.39M
Volume
4.43M
Perf Week
3.14%
Perf Month
6.59%
Perf Quarter
43.75%
Perf Half Y
44.17%
-
-
-
-
Beta
0.525
-
-
Volatility
27.7%, 27.34%
Prev Close
1.02%
Price
1620.55
Change
1.16%

SUNPHARMA.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
119.56134.73138.12160.15180.38
Net income per share
11.1115.6912.113.6435.32
Operating cash flow per share
9.1527.3225.7237.4520.67
Free cash flow per share
-4.2420.8920.8431.2111.98
Cash per share
46.5945.639.8652.7466.3
Book value per share
172.59188.65193.65200.1233.38
Tangible book value per share
135.09151.22156.42160.41172.03
Share holders equity per share
172.59188.65193.65200.1233.38
Interest debt per share
46.0135.8716.715.9129.43
Market cap
1148.92B845.29B1434.32B2194.79B2358.79B
Enterprise value
1183.44B871.67B1410.28B2162.61B2381.45B
P/E ratio
43.122.4549.3967.0627.84
Price to sales ratio
4.012.614.335.715.45
POCF ratio
52.3112.923.2524.4347.56
PFCF ratio
-113.0416.8628.6929.382.08
P/B Ratio
2.771.873.094.574.21
PTB ratio
2.771.873.094.574.21
EV to sales
4.132.74.265.635.5
Enterprise value over EBITDA
16.4511.615.5818.6419.39
EV to operating cash flow
53.8813.322.8624.0748.02
EV to free cash flow
-116.4417.3928.228.8882.87
Earnings yield
0.020.040.020.010.04
Free cash flow yield
-0.010.060.030.030.01
Debt to equity
0.250.180.080.030.12
Debt to assets
0.160.120.060.020.09
Net debt to EBITDA
0.480.35-0.27-0.280.18
Current ratio
1.792.021.892.042
Interest coverage
9.0217.0345.5663.9754.1
Income quality
0.581.312.220.53
Dividend Yield
00.020.010.010.01
Payout ratio
0.180.370.540.660.3
Sales general and administrative to revenue
0.060.070.070.060
Research and developement to revenue
0.070.060.060.060.05
Intangibles to total assets
0.190.190.180.180.22
Capex to operating cash flow
-1.46-0.24-0.19-0.17-0.42
Capex to revenue
-0.11-0.05-0.04-0.04-0.05
Capex to depreciation
-1.83-0.75-0.56-0.7-0.82
Stock based compensation to revenue
00000
Graham number
207.7258.08229.63247.81430.64
ROIC
0.080.080.10.120.13
Return on tangible assets
0.050.070.050.060.14
Graham Net
17.1422.1119.7935.0234.85
Working capital
137.3B159.48B142.96B178.14B199.56B
Tangible asset value
324.13B362.84B375.32B384.88B412.76B
Net current asset value
110.98B125.26B122.55B162.81B184.34B
Invested capital
0.250.180.080.030.12
Average receivables
113.48B123.46B122.87B125.7B124.05B
Average payables
44.57B41.21B40.34B42.27B50.8B
Average inventory
73.83B78.8B84.36B89.97B97.55B
Days sales outstanding
152.04143.88130.31126.4297
Days payables outstanding
163.87142.7146.72139.65194.5
Days of inventory on hand
311.56274.5332.2280.49359.9
Receivables turnover
2.42.542.82.893.76
Payables turnover
2.232.562.492.611.88
Inventory turnover
1.171.331.11.31.01
ROE
0.060.080.060.070.15
Capex per share
-13.39-6.43-4.88-6.23-8.69

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
46.2644.8549.1250.0350.67
Net income per share
9.038.38.439.910.52
Operating cash flow per share
5.55.625.435.275.19
Free cash flow per share
5.55.625.435.275.19
Cash per share
57.6666.5163.0665.720
Book value per share
234.92234.13247.22249.340
Tangible book value per share
0172.580189.250
Share holders equity per share
234.92234.13247.22249.340
Interest debt per share
0.1929.190.348.240.14
Market cap
2402.69B2351.25B2523.14B2779.99B3023.76B
Enterprise value
2541.04B2373.91B2674.44B2745.24B3023.76B
P/E ratio
27.7329.6231.1929.2629.95
Price to sales ratio
21.6521.9221.4123.1624.87
POCF ratio
182.04175.07193.69219.65243.01
PFCF ratio
182.04175.07193.69219.65243.01
P/B Ratio
4.264.24.254.650
PTB ratio
4.264.24.254.650
EV to sales
22.8922.1322.6922.8724.87
Enterprise value over EBITDA
79.9774.7678.3579.0581.13
EV to operating cash flow
192.52176.75205.31216.91243.01
EV to free cash flow
192.52176.75205.31216.91243.01
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.010.010.0100
Debt to equity
00.1200.030
Debt to assets
00.0900.020
Net debt to EBITDA
4.350.714.43-10
Current ratio
0202.620
Interest coverage
54.522733.1257.6289.4
Income quality
0.610.680.640.530.49
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.060.060.060.060.07
Intangibles to total assets
00.2200.220
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
218.44209.07216.54235.680
ROIC
0.040.040.040.040
Return on tangible assets
00.0300.040
Graham Net
57.6634.9663.0654.290
Working capital
138.35B199.56B151.3B243.31B0
Tangible asset value
0412.76B0454.06B0
Net current asset value
138.35B184.34B151.3B231.1B0
Invested capital
00.1200.030
Average receivables
61.93B57.51B57.51B56.83B56.83B
Average payables
25.54B28.41B28.41B28.5B28.5B
Average inventory
49.37B52.57B52.57B49.78B49.78B
Days sales outstanding
096.51085.230
Days payables outstanding
0227.240184.050
Days of inventory on hand
0420.480321.510
Receivables turnover
00.9301.060
Payables turnover
00.400.490
Inventory turnover
00.2100.280
ROE
0.040.040.030.040
Capex per share
00000

SUNPHARMA.NS Frequently Asked Questions

What is Sun Pharmaceutical Industries Limited stock symbol ?

Sun Pharmaceutical Industries Limited is a IN stock and trading under the symbol SUNPHARMA.NS

What is Sun Pharmaceutical Industries Limited stock quote today ?

Sun Pharmaceutical Industries Limited stock price is $1620.55 today.

Is Sun Pharmaceutical Industries Limited stock public?

Yes, Sun Pharmaceutical Industries Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks